ArticleBioinformatics (Oxford, England)2026
HD-AIP: a heterogeneous dual-stream alignment-free framework for anti-inflammatory peptide prediction based on language models and CT-Net.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationAnti-inflammatory peptides (AIPs) show therapeutic potential for treating chronic and autoimmune diseases. Computational screening of these peptides remains challenging because their typically short sequences limit traditional feature extraction effectiveness, while homology-based methods incur high computational costs.
resultsThis study proposes HD-AIP, an alignment-free heterogeneous dual-stream prediction architecture. This framework extracts peptide features in parallel from both macroscopic and microscopic perspectives. Macroscopically, HD-AIP integrates global semantic features extracted by two large protein language models, ProtT5 and ESM-2 3B, with sequence-level physicochemical properties, followed by feature selection and LightGBM classification. Microscopically, an asymmetric parallel network named CT-Net utilizes BioVec embeddings and residue-level physicochemical features, using a CNN branch to capture local motifs and a Transformer branch to model long-range dependencies. The two streams are adaptively fused via a dynamic soft ensemble strategy. On an independent test set, HD-AIP outperforms baseline models across multiple metrics including accuracy, area under the receiver operating characteristic curve, and the Matthews correlation coefficient. These results indicate that HD-AIP improves AIP prediction performance without sequence alignment. This architecture serves as an effective computational tool for the high-throughput virtual screening and candidate discovery of AIPs. AVAILABILITY AND IMPLEMENTATION: You can find the source code and dataset needed on GitHub (https://github.com/Zerofly0/HD-AIP). The required package files have been listed in the readme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.